Cancer cells can outcompete CD8 + T cells for taurine by overexpressing the taurine transporter SLC6A6, leading to taurine depletion in T cells, which induces cell death and dysfunction, thereby promoting tumor progression. This evidence concerns the gene SLC6A6 and cancer.